RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Health Sciences P/S 2024

Health Sciences P/S

0

Health Sciences Dividend yield

Ticker

IWKS

ISIN

US0010582056

As of Jun 2, 2024, Health Sciences's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Health Sciences P/S history

Health Sciences Aktienanalyse

What does Health Sciences do?

The Health Sciences Corp is a company that has been active in the biotechnology industry since 1997. It was founded with the goal of developing practical and innovative solutions for medical problems. The company is based in Toronto, Canada, and operates worldwide. The business model of the Health Sciences Corp includes several divisions, all focused on the field of biotechnology. The main divisions are the development of diagnostic tests, drug development, and the production of medical devices. In the field of diagnostic tests, the Health Sciences Corp offers various products that are intended to contribute to faster and more accurate disease diagnosis. An example of this is the reliable blood glucose test, which is particularly used in the diagnosis of diabetes and other metabolic diseases. The company also offers tests for the detection of infectious diseases such as HIV or hepatitis. In the area of drug development, the Health Sciences Corp focuses on developing innovative solutions for particularly difficult-to-treat diseases. These include cancer, autoimmune, and neurodegenerative diseases. Both completely new active substances and novel combinations of existing therapies are developed for this purpose. In addition to drug development, the company also works on the production of medical products. This includes implants as well as devices for monitoring vital parameters. An example of this is the wireless sensor for monitoring heart rhythm disorders, which is applied to the patient's skin and transfers data to the doctor's mobile phone. Over the years, the Health Sciences Corp has received numerous awards and prizes for technological innovations as well as medical research. The company makes a particularly significant contribution to cancer research. It works closely with renowned research institutions and universities, thus constantly contributing to new findings. The knowledge gained in the process also flows into the development of new therapies. In 2016, the Health Sciences Corp founded a subsidiary called MaRS Innovation, which aims to commercialize technology from Canadian universities. The goal is to transform new technologies that have been researched in universities into commercial products and services. The vision of the Health Sciences Corp is to contribute to sustainably improving healthcare for people worldwide through innovative therapies and medications. In addition, the company places great importance on adhering to ethical and moral standards and behaving respectfully towards the environment and society. Overall, the company has an excellent reputation in the biotechnology industry and is considered a pioneer in the development of practical and innovative solutions for medical problems. Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Health Sciences's P/S Ratio

Health Sciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Health Sciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Health Sciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Health Sciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Health Sciences Stock

What is the price-to-earnings ratio of Health Sciences?

The price-earnings ratio of Health Sciences is currently 0.

How has the price-earnings ratio of Health Sciences changed compared to last year?

The price-to-earnings ratio of Health Sciences has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Health Sciences high compared to other companies?

Yes, the price-to-earnings ratio of Health Sciences is high compared to other companies.

How does an increase in the price-earnings ratio of Health Sciences affect the company?

An increase in the price-earnings ratio of Health Sciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Health Sciences affect the company?

A decrease in the price-earnings ratio of Health Sciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Health Sciences?

Some factors that influence the price-earnings ratio of Health Sciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Health Sciences pay?

Over the past 12 months, Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Health Sciences?

The current dividend yield of Health Sciences is .

When does Health Sciences pay dividends?

Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Health Sciences?

Health Sciences paid dividends every year for the past 0 years.

What is the dividend of Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Health Sciences located?

Health Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Health Sciences from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did Health Sciences pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of Health Sciences in the year 2023?

In the year 2023, Health Sciences distributed 0 USD as dividends.

In which currency does Health Sciences pay out the dividend?

The dividends of Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Health Sciences

Our stock analysis for Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.